Paper · 2843547
Cell surface fibroblast growth factor and epidermal growth factor receptors are permanently lost during skeletal muscle terminal differentiation in culture.
Olwin BB and 1 other. J Cell Biol, 1988. Cited by 189 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Cell surface fibroblast growth factor and epidermal growth factor receptors are permanently lost during skeletal muscle terminal differentiation in culture. Papers, record 2843547. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2843547
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| ErbB Receptors | Major topic |
| Muscles | Major topic |
| Receptors, Cell Surface | Major topic |
| Animals | |
| Autoradiography | |
| Cell Differentiation | |
| Cell Division | |
| Cell Line | |
| Kinetics | |
| Mice | |
| Mitosis | |
| Muscle, Smooth | |
| Phenotype | |
| Receptors, Fibroblast Growth Factor |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| AM 18860 | NIADDK NIH HHS | United States | R01AM018860 | PubMed and NIH |
Source NIH RePORTER
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3,022,285 | Type beta transforming growth factor is an inhibitor of myogenic differentiation. | Proc Natl Acad Sci U S A | 1986 | https://conductscience.org/library/papers/3022285 | PubMed |
| 2 | 3,013,291 | Identification of the fibroblast growth factor receptor of Swiss 3T3 cells and mouse skeletal muscle myoblasts. | Biochemistry | 1986 | https://conductscience.org/library/papers/3013291 | PubMed |
| 3 | 3,465,734 | Regulation of myogenic differentiation by type beta transforming growth factor. | J Cell Biol | 1986 | https://conductscience.org/library/papers/3465734 | PubMed |
| 4 | 3,470,794 | Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. | Proc Natl Acad Sci U S A | 1987 | https://conductscience.org/library/papers/3470794 | PubMed |
| 5 | 2,434,094 | Fibroblast growth factors are present in the extracellular matrix produced by endothelial cells in vitro: implications for a role of heparinase-like enzymes in the neovascular response. | Biochem Biophys Res Commun | 1987 | https://conductscience.org/library/papers/2434094 | PubMed |
| 6 | 2,431,278 | Transcriptional and posttranscriptional control of c-myc during myogenesis: its mRNA remains inducible in differentiated cells and does not suppress the differentiated phenotype. | Mol Cell Biol | 1986 | https://conductscience.org/library/papers/2431278 | PubMed |
| 7 | 3,624,312 | Heterokaryon analysis of muscle differentiation: regulation of the postmitotic state. | J Cell Biol | 1987 | https://conductscience.org/library/papers/3624312 | PubMed |
| 8 | 3,624,313 | Growth factor control of skeletal muscle differentiation: commitment to terminal differentiation occurs in G1 phase and is repressed by fibroblast growth factor. | J Cell Biol | 1987 | https://conductscience.org/library/papers/3624313 | PubMed |
| 9 | 2,894,374 | Decrease in transforming growth factor-beta binding and action during differentiation in muscle cells. | J Biol Chem | 1988 | https://conductscience.org/library/papers/2894374 | PubMed |
| 10 | 13,768,451 | Satellite cell of skeletal muscle fibers. | J Biophys Biochem Cytol | 1961 | https://conductscience.org/library/papers/13768451 | PubMed |
1 to 10 of 37
See all 37 referencesCited by38
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 189 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 34,984,415 | A validated mathematical model of FGFR3-mediated tumor growth reveals pathways to harness the benefits of combination targeted therapy and immunotherapy in bladder cancer. | Comput Syst Oncol | 2021 | https://conductscience.org/library/papers/34984415 | PubMed |
| 34,208,436 | Transdifferentiation of Human Fibroblasts into Skeletal Muscle Cells: Optimization and Assembly into Engineered Tissue Constructs through Biological Ligands. | Biology (Basel) | 2021 | https://conductscience.org/library/papers/34208436 | PubMed |
| 33,419,207 | Upstream Regulator Analysis of Wooden Breast Myopathy Proteomics in Commercial Broilers and Comparison to Feed Efficiency Proteomics in Pedigree Male Broilers. | Foods | 2021 | https://conductscience.org/library/papers/33419207 | PubMed |
| 30,713,094 | EGFR-Aurka Signaling Rescues Polarity and Regeneration Defects in Dystrophin-Deficient Muscle Stem Cells by Increasing Asymmetric Divisions. | Cell Stem Cell | 2019 | https://conductscience.org/library/papers/30713094 | PubMed |
| 28,900,247 | Effects of protease-treated royal jelly on muscle strength in elderly nursing home residents: A randomized, double-blind, placebo-controlled, dose-response study. | Sci Rep | 2017 | https://conductscience.org/library/papers/28900247 | PubMed |
| 26,052,220 | Proliferative Dynamics and the Role of FGF2 During Myogenesis of Rat Satellite Cells on Isolated Fibers. | Basic Appl Myol | 1997 | https://conductscience.org/library/papers/26052220 | PubMed |
| 25,580,445 | Adeno-associated viral (AAV) vectors do not efficiently target muscle satellite cells. | Mol Ther Methods Clin Dev | 2014 | https://conductscience.org/library/papers/25580445 | PubMed |
| 25,078,264 | Transcriptional down-regulation of epidermal growth factor (EGF) receptors by nerve growth factor (NGF) in PC12 cells. | J Mol Neurosci | 2014 | https://conductscience.org/library/papers/25078264 | PubMed |
| 23,967,242 | Epidermal growth factor receptor down-regulation triggers human myoblast differentiation. | PLoS One | 2013 | https://conductscience.org/library/papers/23967242 | PubMed |
| 23,569,208 | Repression of myoblast proliferation and fibroblast growth factor receptor 1 promoter activity by KLF10 protein. | J Biol Chem | 2013 | https://conductscience.org/library/papers/23569208 | PubMed |
1 to 10 of 38
See all 38 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2843547
GET https://conductscience.org/api/papers/v1/2843547/references?page=2